Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03778073 |
| Title | Study of TG-1501 in Subjects With Relapsed or Refractory Lymphoma |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | TG Therapeutics, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| TG Therapeutics Investigational Trial Site | Huntsville | Alabama | 35805 | United States | Details | |
| TG Therapeutics Investigational Trial Site | Tucson | Arizona | 85711 | United States | Details | |
| TG Therapeutics Investigational Trial Site | Fayetteville | Arkansas | 72703 | United States | Details | |
| TG Therapeutics Investigational Trial Site | Peoria | Illinois | 61615 | United States | Details | |
| TG Therapeutics Investigational Trial Site | Fort Wayne | Indiana | 46804 | United States | Details | |
| TG Therapeutics Investigational Trial Site | Fairway | Kansas | 64154 | United States | Details | |
| TG Therapeutics Investigational Trial Site | Louisville | Kentucky | 40207 | United States | Details | |
| TG Therapeutics Investigational Trial Site | Charlotte | North Carolina | 28262 | United States | Details | |
| TG Therapeutics Investigational Trial Site | Seattle | Washington | 98108 | United States | Details |